Codex Labs has announced the launch of the first product in a new collection, KĀNGFÙ, that is focused on healing damaged skin ...
In March 2025, SFA Therapeutics announced that two head-to-head preclinical studies of its oral psoriasis therapy candidate, ...
NICE has recommended delgocitinib cream for adults with moderate-to-severe chronic hand eczema unresponsive to ...
A significant advance in treatment of patients with immunity to AAVs previously ineligible for clinical trials and existing ...
The recent FDA approval of topical JAK inhibitors for children 2 years or older marks a significant advancement in pediatric ...
Detailed price information for Strata Skin Scien (SSKN-Q) from The Globe and Mail including charting and trades.
Described in ACS Nano the method combines LED light and nanoscale tin flakes to neutralize cancer cells while shielding ...
TREMFYA ® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of plaque ...
Despite the fact that this treatment has been around more than 20 years ... Icahn School of Medicine at Mount Sinai a global leader in dermatology and phototherapy research. Robust Clinical Evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback